ALKERMES | ALKS - EPS Earnings Per Share


ALKERMES reported $-0.4 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q2 Jun/2026 -0.02 0.52 Jul/29
FY2026Q1 Mar/2026 -0.40 -0.4 0.13 May/05
FY2025Q4 Dec/2025 0.29 0.42 1.05 Feb/25
FY2025Q3 Sep/2025 0.49 0.4 0.73 Oct/28
FY2025Q2 Jun/2025 0.52 0.39 0.72 Jul/29




Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Acadia Pharmaceuticals USD 0.02 1.58 Mar/2026
ALKERMES USD -0.4 0.69 Mar/2026
Amgen USD 5.15 0.14 Mar/2026
Biogen USD 3.57 1.58 Mar/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Coherus Biosciences USD -0.43 0.06 Dec/2025
Eli Lilly USD 8.55 1.01 Mar/2026
Gilead Sciences USD 2.03 0.17 Mar/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
J&J USD 2.7 0.24 Mar/2026
Malin Corporation EUR -0.06 0.1 Dec/2023
Merck USD -1.28 3.32 Mar/2026
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Neurocrine Biosciences USD 1.94 0.06 Mar/2026
Otsuka Holdings JPY 186.31 62.06 Mar/2026
Ovoca Bio EUR -0.06 0.01 Jun/2025
Pfizer USD 0.75 0.09 Mar/2026
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Vertex Pharmaceuticals USD 4.47 0.56 Mar/2026